Impact of left ventricular end-diastolic wall stress on plasma B-type natriuretic peptide in heart failure with chronic kidney disease and end-stage renal disease.

Impact of left ventricular end-diastolic wall stress on plasma B-type natriuretic peptide in heart failure with chronic kidney disease and end-stage renal disease.

Item
http://www.wikidata.org/entity/Q47748491
Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicabilityTemporal trajectory of B-type natriuretic peptide in patients with CKD stages 3 and 4, dialysis, and kidney transplant.Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fractionImproving prognosis estimation in patients with heart failure and the cardiorenal syndromeThe effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.Tissue Doppler-derived E/e' ratio as a parameter for assessing diastolic heart failure and as a predictor of mortality in patients with chronic kidney disease.Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.Understanding cardiac biomarkers in end-stage kidney disease: Frequently asked questions and the promise of clinical application.Clinical utility of natriuretic peptides in dialysis patients.The diagnostic utility of cardiac biomarkers in dialysis patients.Relationship of left atrial global peak systolic strain with left ventricular diastolic dysfunction and brain natriuretic peptide level in end-stage renal disease patients with preserved left ventricular ejection fraction.Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients.Associates of an elevated natriuretic peptide level in stable heart failure patients: implications for targeted management.The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients
P2860

Impact of left ventricular end-diastolic wall stress on plasma B-type natriuretic peptide in heart failure with chronic kidney disease and end-stage renal disease.

Item
http://www.wikidata.org/entity/Q47748491
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Impact of left ventricular end ...... e and end-stage renal disease.
@en
Impact of left ventricular end ...... e and end-stage renal disease.
@nl
type
label
Impact of left ventricular end ...... e and end-stage renal disease.
@en
Impact of left ventricular end ...... e and end-stage renal disease.
@nl
prefLabel
Impact of left ventricular end ...... e and end-stage renal disease.
@en
Impact of left ventricular end ...... e and end-stage renal disease.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Impact of left ventricular end ...... e and end-stage renal disease.
@en
P2093
P304
P31
P356
10.1373/CLINCHEM.2008.121236
P407
P433
P478
P577
P5875
P698
P921